Evidence map›Paper›PMID 31222511›Full record

ArticleImmunologic research2019

Immune reconstitution after HSCT in SCID-a cohort of conditioned and unconditioned patients.

Uri Manor, Atar Lev, Amos J Simon, Daphna Hutt, Amos Toren, Bella Bielorai, Lior Goldberg, Tali Stauber, Raz Somech

Abstract read
PubMed Publisher
In one paragraph

Article in Immunologic research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Uri ManorSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Atar LevPediatric Immunology Service, Jeffrey Modell Foundation (JMF) Center, Tel HaShomer, Israel.
Amos J SimonPediatric Immunology Service, Jeffrey Modell Foundation (JMF) Center, Tel HaShomer, Israel.
Daphna HuttPediatric Hemato/Oncology Division & Bone Marrow Transplantation Unit, Tel HaShomer, Israel.
Amos TorenSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Bella BieloraiSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Lior GoldbergSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Tali StauberSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Raz SomechSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. raz.somech@sheba.health.gov.il.
Sheba Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is the effective mean of immune restoration in severe combined immunodefiency (SCID). Usually, HSCT without cytoreductive conditioning is attempted. Nevertheless, conditioning procedures are still preferred in a subset of patients. Herein, we describe the immunological outcome in a cohort of conditioned and unconditioned patients, from diagnosis, through transplantation, to follow-up. This retrospective study was conducted on 17 patients with SCID (10 conditioned, 7 unconditioned) who later underwent HSCT. Immune reconstitution was assessed in the post-transplant year by quantification of T cell receptor excision circles (TRECs) and kappa-deleting recombination excision circles (KRECs), among additional laboratory and clinical evaluations. Unconditioned patients were diagnosed and transplanted earlier. TREC and KREC quantification showed a gradual increase in both groups, with higher levels in the conditioned group. Engraftment percentages differed drastically between groups, favoring the conditioned group. Unconditioned patients were significantly more dependent on intravenous immunoglobulins (IVIGs). One patient from each group succumbed to disease complications. Conditioning demonstrated superior laboratorial outcomes. Patients with unique characteristics (i.e., consanguinity, Bacillus Calmette-Guérin vaccination, impaired access to IVIG) may require personalized considerations. The effort to implement secondary prevention of SCID with newborn screening should continue.

Indexed as

Hematopoietic Stem Cell TransplantationImmune ReconstitutionTransplantation ConditioningDisease SusceptibilityFollow-Up StudiesGraft SurvivalGraft vs Host DiseaseHumansImmunity, CellularImmunity, HumoralImmunoglobulins, IntravenousSevere Combined ImmunodeficiencyTransplantation, HomologousTreatment OutcomeImmunoglobulins, IntravenousConditioningHematopoietic stem cell transplantation (HSCT)Kappa-deleting recombination excision circles (KRECs)Primary immunodeficiency (PID)Severe combined immunodeficiency (SCID)T cell receptor excision circles (TRECs)

Identifiers

PMID31222511
OpenAlexW2952548451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.